Drug Type Small molecule drug |
Synonyms R-93777 |
Target |
Mechanism 5-HT3 receptor antagonists(Serotonin 3 (5-HT3) receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dyspepsia | Phase 1 | - | - | |
Dyspepsia | Phase 1 | - | - | |
Irritable Bowel Syndrome | Phase 1 | - | - | |
Irritable Bowel Syndrome | Phase 1 | - | - | |
Nausea | Phase 1 | - | - | |
Nausea | Phase 1 | - | - | |
Vomiting | Phase 1 | - | - | |
Vomiting | Phase 1 | - | - |